Equip EHV Injection (10 Dose)

   Product Ref: DUEQU11 Category: E

343.58


Vat Rate: 20%

Prescription Required



For active immunisation of horses to reduce clinical signs due to infection with Equine Herpesvirus 1 and 4 and to reduce abortion caused by EHV-1 infection.
Vat Rate: 20%

Royal Mail 2nd Class / Parcel Force 48

UK to UK :Normally arrives in 2-4 business days.

UK to Ireland :Normally arrives in 4-6 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note standered delivery is none trackable , none insured , no responsabily for lose or Damage

 

----------------------------------------------------------------------------------------------------------------

 

Royal Mail First Class / Parcel Force 24

UK to UK :Normally arrives in 1-2 business days.

UK to Ireland 3-4 business days

UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going

 

Please note :Trackable , Royal Mail insured up to £50.

 

--------------------------------------------------------------------------------------------------------

Parcel Force Express AM Guaranteed before Midday.

UK to UK only . UP to 5KG Max Weight

Arrives next day before 12 noon, requires a signature.

 

Parcel Forcel Terms & Conditions apply

 

Important: Parcel Force advise that there are some postcodes where an extended delivery time exists, and may affect the date of delivery or the service is not available.

 

You must be logged in to write review
Category POM-V
Temperature Refrigerated
MA/VM/EU No: 42058/4060
Species
VMD Link Product Information Database (defra.gov.uk)
NOAH Link https://www.noahcompendium.co.uk/?id=-457308
Dosage One dose per horse to be administered by deep intramuscular injection. Primary course A single dose should be administered from 5 months of age followed by a second injection after an interval of 4-6 weeks. In the event of increased infection risk, for example when a foal has consumed insufficient colostrum or there is a risk of early exposure to field infections with EHV-1 or EHV-4, earlier vaccination may be given. In these circumstances the foal should receive a single dose from 3 months of age followed by the above mentioned full primary vaccination course. Booster Following completion of the primary course, a single dose should be administered every 6 months. Use in pregnant mares To reduce abortion due to EHV-1 infection, pregnant mares should be vaccinated during the 5th, 7th and 9th month of pregnancy with a single 1.5 ml dose on each occasion.
Withdrawals Do not vaccinate unhealthy horses. Can be used during pregnancy. No information is available on the compatibility of this vaccine with any other. Therefore the safety and efficacy of this product when used with any other (either when used on the same day or at different times) has not been demonstrated. Do not mix with any other medicinal product. The vaccine may not be effective in animals incubating the disease at the time of vaccination. In the event of an allergic or anaphylactic reaction, immediate treatment should be given with a soluble glucocorticoid intravenously (e.g. dexamethasone sodium phosphate), adrenaline intramuscularly or anti-histamine intramuscularly. Animals that have received immunosuppressive drugs (e.g. glucocorticoids) should not be vaccinated until an interval of at least 4 weeks has elapsed. Syringes and needles should not have been sterilised chemically or be above ambient temperature. Do not use chemicals to disinfect or sterilise the skin. Shake well before use. Aseptic precautions should be observed. Adverse Reactions A transient local swelling at the injection site was very commonly observed. Usually, the local swelling does not measure more than 5 cm in diameter and disappears within a few to 6 days post vaccination. A transient increase in rectal temperature during up to 2 days following dosing not exceeding 1.7